A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response

References

• Alsop BR, Sharma P. Esophageal cancer. Gastroenterol Clin North Am. 2016;45:399–412. doi:10.1016/j.gtc.2016.04.001
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Su Z, Zou GR, Mao YP, et al. Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. J Cancer. 2019;10:1349–1357. doi:10.7150/jca.26511
   PubMed Web of Science ®Google Scholar
• Malhotra GK, Yanala U, Ravipati A, et al. Global trends in esophageal cancer. J Surg Oncol. 2017;115:564–579. doi:10.1002/jso.24592
   PubMed Web of Science ®Google Scholar
• Vioque J, Barber X, Bolumar F, et al. Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer. 2008;8:221. doi:10.1186/1471-2407-8-221
   PubMed Web of Science ®Google Scholar
• Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245:717–725. doi:10.1097/01.sla.0000251703.35919.02
   PubMed Web of Science ®Google Scholar
• Long E, Beales IL. The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol. 2014;7:247–268. doi:10.1177/1756283x14538689
   PubMed Web of Science ®Google Scholar
• Jang R, Darling G, Wong RK. Multimodality approaches for the curative treatment of esophageal cancer. J Natl Compr Canc Netw. 2015;13:229–238. doi:10.6004/jnccn.2015.0029
   PubMed Web of Science ®Google Scholar
• Kojima T, Shah MA, Muro K, et al. Randomized Phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer. J Clin Oncol. 2020;38:4138–4148. doi:10.1200/jco.20.01888
   PubMed Web of Science ®Google Scholar
• Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther. 2020;5:229. doi:10.1038/s41392-020-00323-3
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. A physiological function for ferroptosis in tumor suppression by the immune system. Cell Metab. 2019;30:14–15. doi:10.1016/j.cmet.2019.06.012
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shi J, Liu X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181–1192. doi:10.1038/s41556-018-0178-0
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30:478–490. doi:10.1016/j.tcb.2020.02.009
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273–285. doi:10.1016/j.cell.2017.09.021
   PubMed Web of Science ®Google Scholar
• Green DR. The coming decade of cell death research: five riddles. Cell. 2019;177:1094–1107. doi:10.1016/j.cell.2019.04.024
   PubMed Web of Science ®Google Scholar
• Wang W, Green M, Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270–274. doi:10.1038/s41586-019-1170-y
   PubMed Web of Science ®Google Scholar
• Lang X, Green MD, Wang W, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9:1673–1685. doi:10.1158/2159-8290.Cd-19-0338
   PubMed Web of Science ®Google Scholar
• Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell. 2011;145:178–181. doi:10.1016/j.cell.2011.03.014
   PubMed Web of Science ®Google Scholar
• Mi X, Xu R, Hong S, et al. M2 macrophage-derived exosomal lncRNA AFAP1-AS1 and microRNA-26a affect cell migration and metastasis in esophageal cancer. Mol Ther Nucleic Acids. 2020;22:779–790. doi:10.1016/j.omtn.2020.09.035
   PubMedGoogle Scholar
• Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96–118. doi:10.1038/s41580-020-00315-9
   PubMed Web of Science ®Google Scholar
• Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18:962–972. doi:10.1038/ni.3771
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhang X, Gu X, Li X, Shang L. Progress in understanding the role of lncRNA in programmed cell death. Cell Death Discov. 2021;7:30. doi:10.1038/s41420-021-00407-1
   PubMed Web of Science ®Google Scholar
• Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31:4577–4587. doi:10.1038/onc.2011.621
   PubMed Web of Science ®Google Scholar
• Zhu L, Yang F, Wang L, et al. Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma. Cancer Cell Int. 2021;21:124. doi:10.1186/s12935-021-01821-2
   PubMed Web of Science ®Google Scholar
• Lu T, Xu R, Li Q, et al. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma. Mol Ther Oncolytics. 2021;21:134–143. doi:10.1016/j.omto.2021.02.011
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhou Z, Qiu Y, et al. A prognostic ferroptosis-related lncRNAs signature associated with immune landscape and radiotherapy response in glioma. Front Cell Dev Biol. 2021;9:675555. doi:10.3389/fcell.2021.675555
   PubMed Web of Science ®Google Scholar
• Wu ZH, Tang Y, Yu H, Li HD. The role of ferroptosis in breast cancer patients: a comprehensive analysis. Cell Death Discov. 2021;7:93. doi:10.1038/s41420-021-00473-5
   PubMed Web of Science ®Google Scholar
• Tang Y, Li C, Zhang YJ, Wu ZH. Ferroptosis-related long non-coding RNA signature predicts the prognosis of head and neck squamous cell carcinoma. Int J Biol Sci. 2021;17:702–711. doi:10.7150/ijbs.55552
   PubMed Web of Science ®Google Scholar
• Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database. 2020;2020, baaa021. doi:10.1093/database/baaa021
   Google Scholar
• Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31:2912–2914. doi:10.1093/bioinformatics/btv300
   PubMed Web of Science ®Google Scholar
• Hong W, Liang L, Gu Y, et al. Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma. Mol Ther Nucleic Acids. 2020;22:937–947. doi:10.1016/j.omtn.2020.10.002
   PubMedGoogle Scholar
• Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315–1316. doi:10.1097/JTO.0b013e3181ec173d
   PubMed Web of Science ®Google Scholar
• Zhang Z. Survival analysis in the presence of competing risks. Ann Transl Med. 2017;5:47. doi:10.21037/atm.2016.08.62
   PubMed Web of Science ®Google Scholar
• Ranstam J, Cook JA. Kaplan-Meier curve. Br J Surg. 2017;104:442. doi:10.1002/bjs.10238
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509–w514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Sturm G, Finotello F, Petitprez F, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436–i445. doi:10.1093/bioinformatics/btz363
   PubMed Web of Science ®Google Scholar
• Merino DM, McShane LM, Fabrizio D, et al. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: Phase I of the friends of cancer research TMB harmonization project. J Immunother Cancer. 2020;8:e000147. doi:10.1136/jitc-2019-000147
   PubMed Web of Science ®Google Scholar
• Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747–1756. doi:10.1101/gr.239244.118
   PubMed Web of Science ®Google Scholar
• Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 2014;9:e107468. doi:10.1371/journal.pone.0107468
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165–176. doi:10.1016/j.tcb.2015.10.014
   PubMed Web of Science ®Google Scholar
• Lin EW, Karakasheva TA, Hicks PD, Bass AJ, Rustgi AK. The tumor microenvironment in esophageal cancer. Oncogene. 2016;35:5337–5349. doi:10.1038/onc.2016.34
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen Z, Han Y, et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat Commun. 2020;11:6268. doi:10.1038/s41467-020-20019-0
   PubMed Web of Science ®Google Scholar
• Horisberger A, La Rosa S, Zurcher JP, et al. A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy. J Immunother Cancer. 2018;6:156. doi:10.1186/s40425-018-0481-0
   PubMed Web of Science ®Google Scholar
• Chandra Gupta S, Nandan Tripathi Y. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140:1955–1967. doi:10.1002/ijc.30546
   PubMed Web of Science ®Google Scholar
• Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26:2329–2343. doi:10.1038/s41418-019-0304-y
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen X, Liu N, et al. A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol Ther. 2021;29:263–274. doi:10.1016/j.ymthe.2020.09.024
   PubMed Web of Science ®Google Scholar
• Weng NQ, Chi J, Wen J, et al. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis. J Transl Med. 2020;18:47. doi:10.1186/s12967-020-02224-z
   PubMed Web of Science ®Google Scholar
• Xie JJ, Jiang YY, Jiang Y, et al. Super-enhancer-driven long non-coding RNA LINC01503, regulated by TP63, is over-expressed and oncogenic in squamous cell carcinoma. Gastroenterology. 2018;154:2137–2151.e2131. doi:10.1053/j.gastro.2018.02.018
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang Q, Lou Q, et al. Differential analysis of lncRNA, miRNA and mRNA expression profiles and the prognostic value of lncRNA in esophageal cancer. Pathol Oncol Res. 2020;26:1029–1039. doi:10.1007/s12253-019-00655-8
   PubMed Web of Science ®Google Scholar
• Gao M, Guo R, Lu X, Xu G, Luo S. Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis. Thorac Cancer. 2020;11:2398–2405. doi:10.1111/1759-7714.13534
   PubMed Web of Science ®Google Scholar
• Kudo T, Hamamoto Y, Kato K, et al. Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, Phase 2 trial. Lancet Oncol. 2017;18:631–639. doi:10.1016/s1470-2045(17)30181-x
   PubMed Web of Science ®Google Scholar
• Shah MA, Kojima T, Hochhauser D, et al. Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE-180 study. JAMA Oncol. 2019;5:546–550. doi:10.1001/jamaoncol.2018.5441
   PubMed Web of Science ®Google Scholar
• Wang L, Wei Q, Zhang M, et al. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients. Int Immunopharmacol. 2020;87:106795. doi:10.1016/j.intimp.2020.106795
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang Q, Xu M, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer. 2020;19:41. doi:10.1186/s12943-020-01165-x
   PubMed Web of Science ®Google Scholar
• Zhou J, Zheng S, Liu T, et al. IL-1β from M2 macrophages promotes migration and invasion of ESCC cells enhancing epithelial-mesenchymal transition and activating NF-κB signaling pathway. J Cell Biochem. 2018;119:7040–7052. doi:10.1002/jcb.26918
   PubMed Web of Science ®Google Scholar
• Sun L, Pan J, Yu L, et al. Tumor endothelial cells promote metastasis and cancer stem cell-like phenotype through elevated Epiregulin in esophageal cancer. Am J Cancer Res. 2016;6:2277–2288.
   PubMed Web of Science ®Google Scholar
• Rana J, Biswas M. Regulatory T cell therapy: current and future design perspectives. Cell Immunol. 2020;356:104193. doi:10.1016/j.cellimm.2020.104193
   PubMed Web of Science ®Google Scholar
• Sawant DV, Yano H, Chikina M, et al. Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion. Nat Immunol. 2019;20:724–735. doi:10.1038/s41590-019-0346-9
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Semeraro M, Adam J, et al. Immunosurveillance in esophageal carcinoma: the decisive impact of regulatory T cells. Oncoimmunology. 2016;5:e1064581. doi:10.1080/2162402x.2015.1064581
   PubMed Web of Science ®Google Scholar
• Lian J, Liu S, Yue Y, et al. Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway. Cancer Sci. 2021;112:144–154. doi:10.1111/cas.14712
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu S, Chen X, et al. L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma. Cancer Biol Med. 2021;18(2):547–561. doi:10.20892/j.issn.2095-3941.2020.0182
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li Y, Lian J, et al. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer. J Transl Med. 2019;17:165. doi:10.1186/s12967-019-1917-0
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li Y, Tang B, et al. IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2020;69:2371–2380. doi:10.1007/s00262-020-02629-1
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang G, Wang J, et al. The role of cancer-associated fibroblasts in esophageal cancer. J Transl Med. 2016;14:30. doi:10.1186/s12967-016-0788-x
   PubMed Web of Science ®Google Scholar
• Kato T, Noma K, Ohara T, et al. Cancer-associated fibroblasts affect intratumoral CD8(+) and FoxP3(+) T cells via IL6 in the tumor microenvironment. Clin Cancer Res. 2018;24:4820–4833. doi:10.1158/1078-0432.Ccr-18-0205
   PubMed Web of Science ®Google Scholar
• Zhang H, Hua Y, Jiang Z, et al. Cancer-associated fibroblast-promoted LncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma. Clin Cancer Res. 2019;25:1989–2000. doi:10.1158/1078-0432.Ccr-18-0773
   PubMed Web of Science ®Google Scholar
• Chan TA, Yarchoan M, Jaffee E, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30:44–56. doi:10.1093/annonc/mdy495
   PubMed Web of Science ®Google Scholar
• Kakeji Y, Oshikiri T, Takiguchi G, et al. Multimodality approaches to control esophageal cancer: development of chemoradiotherapy, chemotherapy, and immunotherapy. Esophagus. 2021;18:25–32. doi:10.1007/s10388-020-00782-1
   PubMed Web of Science ®Google Scholar